CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Alnylam cuts Amvuttra sales guidance as demand shifts, hurting stock

EarningsAmvuttraNegative
AI Analysis

Summary

Alnylam lowered its full-year sales guidance for Amvuttra in its second-quarter earnings report, citing demand shifts and hurting investor confidence during a difficult year for the company.

Financial Highlights

Guidance

lowered

Outcome Details

Lowered full-year sales projection

Importance:6/10
Sentiment:
-0.70
earningsguidance reductionsales declineAmvuttra
Related Companies

Read the original article

Published by Endpoints News on July 30, 2026 1:25 PM

Read Original